Author:
Dassi Manisha,Aggarwal Garima,Jha Lakshmi K.,Aggarwal Neeru P.
Abstract
Diffuse Large B Cell Lymphoma is the commonest subtype of Non-Hodgkin’s Lymphoma. It may present with primary nodal or extranodal involvement. Up to 40% of patients present with primary extranodal involvement, the commonest involved sites being gastrointestinal tract, testes, central nervous system, thyroid, nose, sinuses, skin, breast, bone and respiratory tract. Skeletal Muscle is a rare site of primary lymphomatous involvement. We present a case of Diffuse Large B Cell lymphoma primarily involving the skeletal muscles and breast, initially managed as a case of acute pyogenic myositis with sepsis with Multiple Organ Dysfunction Syndrome. In addition, the patient had hypercalcemia, cortical vein thrombosis, proteinuria and renal dysfunction, which were all speculated to be paraneoplastic in etiology.
Publisher
Bentham Science Publishers Ltd.
Reference13 articles.
1. Prakash G, Sharma A, Raina V, Kumar L, Sharma MC, Mohanti BK.
B cell non-Hodgkin’s lymphoma: Experience from a tertiary care cancer center.
Ann Hematol
2012;
91
(10)
: 1603-11.
2. American Cancer Society.
Cancer Facts & Figures
2018.
https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2018/cancer-facts-and-figures-2018.pdf
3. McGuire S.
World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015.
Adv Nutr
2016;
7
(2)
: 418-9.
4. De Paepe P, De Wolf-Peeters C.
Diffuse large B-cell lymphoma: A heterogeneous group of non-Hodgkin lymphomas comprising several distinct clinicopathological entities.
Leukemia
2007;
21
(1)
: 37-43.
5. Møller MB, Pedersen NT, Christensen BE.
Diffuse large B-cell lymphoma: Clinical implications of extranodal versus nodal presentation-a population-based study of 1575 cases.
Br J Haematol
2004;
124
(2)
: 151-9.